Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis

Clinical trial NCT07546552 · RECRUITING

Trial details

NCT number: NCT07546552
Sponsor: Peter Humaidan
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Female Infertility NF-κB Ligand RANKL Osteoporosis Follicle Development

Start date: 2025-08-01
Primary completion: 2028-03-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.